|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/437 | (2006.01) |
| A61K 31/437 | (2013.01) | ||
| A61K 38/21 | (2006.01) | ||
| A61K 38/215 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/28 | (2018.01) |
| (11) | Number of the document | 3863628 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19794366.5 |
| Date of filing the European patent application | 2019-10-08 | |
| (97) | Date of publication of the European application | 2021-08-18 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/055167 |
| Date | 2019-10-08 |
| (87) | Number | WO 2020/076809 |
| Date | 2020-04-16 |
| (30) | Number | Date | Country code |
| 201862743449 P | 2018-10-09 | US |
| (72) |
MATSUDA, Kazuko , US
|
| (73) |
MediciNova, Inc. ,
4275 Executive Square
Suite 300, La Jolla, CA 92037,
US
|
| (54) | COMBINATION OF IBUDILAST AND INTERFERON-BETA AND METHODS OF USING SAME |
| COMBINATION OF IBUDILAST AND INTERFERON-BETA AND METHODS OF USING SAME |